Portfolio / Omrix

Omrix.gif


Prior to its acquisition by J&J, Omrix Biopharmaceuticals developed, manufactured, and marketed biological products for the biosurgical and immunotherapy markets.

The company was initially listed on NASDAQ prior to the acquisition by J&J.

Company: omrix

Fund: alpinvest

Status: Realized

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

Therapeutics

Icons-Creteria_Medical-technologymedical-devices.png